Contineum Therapeutics (CTNM) PT Raised to $23 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CTNM Hot Sheet
Price: $12.48 +0.81%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on Contineum Therapeutics (NASDAQ: CTNM) to $23.00 (from $21.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Sony Financial Holdings (8729:JP) (SNYFY) PT Lowered to JPY180 at Nomura/Instinet
- Meituan Dianping (3690:HK) (MPNGF) PT Lowered to HK$93 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
